Veenat Imatinib Tablets 400mg

Q1: What is Veenat Imatinib 400mg used for?

Imatinib 400mg is a targeted tyrosine kinase inhibitor used for chronic myeloid leukemia (CML) with Philadelphia chromosome (BCR-ABL positive), gastrointestinal stromal tumors (GIST) with KIT mutations, and other BCR-ABL or PDGFR-driven malignancies.

Q2: How does Imatinib work against CML and GIST?

Imatinib competitively inhibits the BCR-ABL fusion tyrosine kinase in CML cells and c-KIT tyrosine kinase in GIST cells. By blocking these constitutively active kinases, it prevents the abnormal signaling that drives uncontrolled tumor cell proliferation and inhibits apoptosis.

Q3: What genetic test is required before starting Imatinib?

For CML: Philadelphia chromosome (Ph+) or BCR-ABL fusion gene confirmation. For GIST: KIT (CD117) or PDGFRA mutation analysis. Without these mutations confirmed, Imatinib is unlikely to be effective.

Q4: How is Imatinib 400mg taken?

Take 400mg once daily with a meal and a large glass of water (reduces nausea). For CML in blast phase: dose may be increased to 600–800mg. Do not crush tablets. Take at a consistent time each day.

Q5: What are the most common side effects?

Nausea, diarrhea, vomiting, peripheral edema (ankle/face swelling), fatigue, muscle cramps, rash, and abdominal pain are most common. Muscle cramps affect ~40% and can be managed with electrolyte supplementation.

Q6: What is the fluid retention/edema risk?

Imatinib commonly causes peripheral edema (40–60%). Weight monitoring and diuretics may be needed. Severe fluid retention causing pleural effusion, pericardial effusion, or pulmonary edema requires dose reduction or treatment interruption.

Q7: What serious side effects require emergency care?

Seek immediate care for: severe fluid retention (severe edema, shortness of breath — pulmonary or pericardial effusion), GI perforation (GIST patients), severe hepatotoxicity (jaundice, dark urine), or severe cytopenias (infection risk from neutropenia).

Q8: How does Imatinib interact with HIV medications?

Strong CYP3A4 inhibitors (ritonavir, cobicistat-boosted PIs) increase Imatinib levels significantly. Strong CYP3A4 inducers (efavirenz, rifampicin) reduce Imatinib efficacy. Coordination between HIV and oncology specialists is essential.

Q9: What blood tests are required during Imatinib therapy?

Complete blood count (CBC) weekly for the first month, biweekly for the second month, then monthly. Liver function tests at baseline and monthly for the first year. BCR-ABL molecular response monitoring every 3 months.

Q10: Is Imatinib safe during pregnancy?

Imatinib is teratogenic — it causes fetal harm including skeletal abnormalities. It should not be used in pregnancy. Effective contraception is required during treatment. Women should not become pregnant while on Imatinib.

Q11: How should Veenat 400mg be stored?

Store at room temperature below 30°C, away from moisture and light. Keep in original packaging out of reach of children.

Q12: Do I need a prescription for Veenat Imatinib?

Yes. Imatinib is a prescription-only oncology drug requiring specialist prescribing, genetic testing confirmation, and regular blood count and liver function monitoring.